1 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Phantom Limb: new trials by email Literature Review of Phantom Limb trials Research Report on Phantom Limb
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved. IM ketamine in dose finding and then continuation - Phantom Limb Syndrome With Pain | Phase 2 / Phase 3 | Recruiting | The Ketamine Research Foundation | 30 | 2026-01-15 | 2026-03-18 |
Pain (1)
Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Pain, Postoperative (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Perceptual Disorders (1) · Postoperative Complications (1) · Signs and Symptoms (1)
The Ketamine Research Foundation (1)
United States (1)